Condition
Diabetes; Nephropathy (Manifestation)
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05810311Phase 2Not Yet Recruiting
The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy
NCT05787990Unknown
Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular Complications
NCT03965975Not ApplicableUnknown
Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device
Showing all 3 trials